Avicanna Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Public

  • Employees
  • 37

Employees

  • Stock Symbol
  • AVCN

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $0.06
  • (As of Wednesday Closing)

Avicanna General Information

Description

Avicanna Inc is a commercial-stage international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for the medical and pharmaceutical market segments. It has three operating segments: Canada, International, and Corporate. It generates the majority of its revenue from Canada.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 480 University Avenue
  • Suite 1502
  • Toronto, Ontario M5G 1V2
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
TSE
Corporate Office
  • 480 University Avenue
  • Suite 1502
  • Toronto, Ontario M5G 1V2
  • Canada

Avicanna Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avicanna Stock Performance

As of 18-Nov-2026, Avicanna’s stock price is $0.06. Its current market cap is $8.22M with 134M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.06 $0.06 $0.06 - $0.20 $8.22M 134M 182K -$0.02

Avicanna Financials Summary

As of 30-Jun-2026, Avicanna has a trailing 12-month revenue of $18.3M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 17,079 25,288 28,087 27,894
Revenue 18,314 18,218 18,565 12,434
EBITDA (2,155) (1,405) (2,474) (5,447)
Net Income (2,763) (2,034) (2,912) (6,474)
Total Assets 16,980 15,510 13,527 16,562
Total Debt 119 0 76 1,359
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Avicanna Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avicanna‘s full profile, request access.

Request a free trial

Avicanna Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Avicanna Inc is a commercial-stage international biopharmaceutical company focused on the development, advancement, and
Drug Discovery
Toronto, Canada
37 As of 2026

Toronto, Canada
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Avicanna Competitors (2)

One of Avicanna’s 2 competitors is Quantum BioPharma, a Corporation company based in Toronto, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Quantum BioPharma Corporation Toronto, Canada
Lite Strategy Corporation San Diego, CA
You’re viewing 2 of 2 competitors. Get the full list »

Avicanna Patents

Avicanna Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3239914-A1 Oral cannabinoid compositions and methods for treating neurological diseases and disorders Pending 03-Dec-2021
US-20250032520-A1 Oral cannabinoid compositions and methods for treating neurological diseases and disorders Pending 03-Dec-2021
WO-2023100138-A1 Oral cannabinoid compositions and methods for treating neurological diseases and disorders Inactive 03-Dec-2021
WO-2023047308-A1 Methods for reducing or eliminating incidence of seizures and sudden unexpected death in epilepsy Inactive 22-Sep-2021
US-12064461-B2 Deep penetrating topical cannabinoid compositions and methods for treating musculoskeletal inflammation and pain Active 16-Jul-2021 A61K36/3482
To view Avicanna’s complete patent history, request access »

Avicanna Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avicanna Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Avicanna‘s full profile, request access.

Request a free trial

Avicanna Investments & Acquisitions (4)

Avicanna’s most recent deal was a Merger/Acquisition with MyMedi.ca for . The deal was made on 31-Jul-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MyMedi.ca 31-Jul-2023 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Sigma Magdalena 08-Aug-2019 Joint Venture Laboratory Services (Healthcare)
Sativa Nativa 31-Dec-2018 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Santa Marta Golden Hemp 16-Aug-2018 Merger/Acquisition Cultivation
To view Avicanna’s complete investments and acquisitions history, request access »

Avicanna ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Avicanna’s complete esg history, request access »

Avicanna Exits (1)

Avicanna’s most recent exit was on 31-Dec-2018 from Sativa Nativa. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Sativa Nativa 31-Dec-2018 Completed
To view Avicanna’s complete exits history, request access »

Avicanna Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
MyMedi.ca Toronto, Canada 2019

Avicanna FAQs

  • When was Avicanna founded?

    Avicanna was founded in 2016.

  • Where is Avicanna headquartered?

    Avicanna is headquartered in Toronto, Canada.

  • What is the size of Avicanna?

    Avicanna has 37 total employees.

  • What industry is Avicanna in?

    Avicanna’s primary industry is Drug Discovery.

  • Is Avicanna a private or public company?

    Avicanna is a Public company.

  • What is Avicanna’s stock symbol?

    The ticker symbol for Avicanna is AVCN.

  • What is the current stock price of Avicanna?

    As of 18-Nov-2026 the stock price of Avicanna is $0.06.

  • What is the current market cap of Avicanna?

    The current market capitalization of Avicanna is $8.22M.

  • What is Avicanna’s current revenue?

    The trailing twelve month revenue for Avicanna is $18.3M.

  • Who are Avicanna’s competitors?

    Quantum BioPharma and Lite Strategy are competitors of Avicanna.

  • What is Avicanna’s annual earnings per share (EPS)?

    Avicanna’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process